Corcept Therapeutics
CORT
CORT
225 hedge funds and large institutions have $2.02B invested in Corcept Therapeutics in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 75 increasing their positions, 90 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
225
Holders Change
-3
Holders Change %
-1.32%
% of All Funds
3.8%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
25
Increased
75
Reduced
90
Closed
21
Calls
$4.45M
Puts
$6.06M
Net Calls
-$1.61M
Net Calls Change
-$4.82M
Top Buyers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$60.1M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$132M |
| 3 |
PA
Parallel Advisors
San Francisco,
California
|
$64.6M |
| 4 |
D.E. Shaw & Co
New York
|
$38.3M |
| 5 |
Franklin Resources
San Mateo,
California
|
$6.05M |
Top Sellers
| 1 |
Millennium Management
New York
|
$14.6M |
| 2 |
SG Americas Securities
New York
|
$868K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$235M |
| 4 |
Man Group
London,
United Kingdom
|
$26.3M |
| 5 |
UBS Group
Zurich,
Switzerland
|
$764K |
